Doubts cast over long-term benefit of bariatric surgery

Image
ANI Washington
Last Updated : Jun 05 2013 | 4:00 PM IST

A review of more than 30 studies found that diabetic people with moderate obesity lost more weight and had better glucose control over two years if they were treated with bariatric surgery rather than non-surgical alternatives like dieting and medications, a new study suggests.

However, the findings come from a relatively small number of trials performed at only a few academic surgery centers.

More information is needed about how patients fare after two or more years, including complication rates and side effects, before the strategy can be more widely recommended, according to researchers.

"Bariatric surgery for diabetic people who are not severely obese has shown promising results in controlling glucose," Dr. Melinda Maggard-Gibbons, the study's lead author and a surgeon at the David Geffen School of Medicine at UCLA, said.

"However, we need more information about the long-term benefits and risks before recommending bariatric surgery over non-surgical weight-loss treatment for these individuals," she said.

Bariatric surgery, which includes procedures such as gastric banding and gastric bypass, is now commonly used to produce weight loss and help manage related illnesses in people who are severely obese-generally people who are 100 pounds or more overweight.

Bariatric surgery is being advocated as a treatment for diabetes in less-obese individuals, but there is no consensus about whether it's appropriate.

In 2006, the federal Centers for Medicare and Medicaid Services would not approve coverage for patients with lower BMI and diabetes, whereas the US Food and Drug Administration has approved gastric banding for individuals with a BMI of 30 to 35 who have an obesity-related illness.

Before recommending weight-loss surgery for people on the lower end of the obesity spectrum, there needs to be additional and larger studies done to demonstrate the value of the approach, according to the study.

The study is published in the Journal of the American Medical Association.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 05 2013 | 3:43 PM IST

Next Story